BACKGROUND: Nodular melanoma (NM) may be biologically aggressive compared with the more common superficial spreading melanoma (SSM), with recent data suggesting underlying genetic differences between these 2 subtypes. To better define the clinical behavior of NMs, the authors compared their clinical and histopathologic features to those of SSMs at their institution, a tertiary referral center, over 3 decades. METHODS: A total of 1,684 patients diagnosed with 1,734 melanomas were prospectively enrolled. Of these, 1,143 patients (69% SSM, 11% NM, 20% other) were diagnosed between 1972 and 1982; 541 patients (54% SSM, 23% NM, 23% other) were diagnosed between 2002 and the present. Differences between the features of NM and SSM within each time period as well as changes over time were analyzed. RESULTS: The authors found that SSMs are now diagnosed as thinner lesions (P < .0001) with a low incidence of histologic ulceration (P < .0001), whereas there was no significant change in the median tumor thickness or ulceration status of NMs over time (P = .10, P = .30, respectively). The median age at diagnosis of NM, however, did significantly increase over time (51 years to 63 years, P < .01). The median duration of NMs was reported to be only 5 months compared with 9 months in SSM patients. CONCLUSIONS: The authors' data suggest that improvements have been made in the early detection of SSM but not NM. Modifications of current screening practices, including increased surveillance of high-risk patients with an emphasis on the "E" for "evolution" criterion of the ABCDE acronym used for early detection of melanoma, are thus warranted.
BACKGROUND:Nodular melanoma (NM) may be biologically aggressive compared with the more common superficial spreading melanoma (SSM), with recent data suggesting underlying genetic differences between these 2 subtypes. To better define the clinical behavior of NMs, the authors compared their clinical and histopathologic features to those of SSMs at their institution, a tertiary referral center, over 3 decades. METHODS: A total of 1,684 patients diagnosed with 1,734 melanomas were prospectively enrolled. Of these, 1,143 patients (69% SSM, 11% NM, 20% other) were diagnosed between 1972 and 1982; 541 patients (54% SSM, 23% NM, 23% other) were diagnosed between 2002 and the present. Differences between the features of NM and SSM within each time period as well as changes over time were analyzed. RESULTS: The authors found that SSMs are now diagnosed as thinner lesions (P < .0001) with a low incidence of histologic ulceration (P < .0001), whereas there was no significant change in the median tumor thickness or ulceration status of NMs over time (P = .10, P = .30, respectively). The median age at diagnosis of NM, however, did significantly increase over time (51 years to 63 years, P < .01). The median duration of NMs was reported to be only 5 months compared with 9 months in SSM patients. CONCLUSIONS: The authors' data suggest that improvements have been made in the early detection of SSM but not NM. Modifications of current screening practices, including increased surveillance of high-risk patients with an emphasis on the "E" for "evolution" criterion of the ABCDE acronym used for early detection of melanoma, are thus warranted.
Authors: C M Balch; A C Buzaid; S J Soong; M B Atkins; N Cascinelli; D G Coit; I D Fleming; J E Gershenwald; A Houghton; J M Kirkwood; K M McMasters; M F Mihm; D L Morton; D S Reintgen; M I Ross; A Sober; J A Thompson; J F Thompson Journal: J Clin Oncol Date: 2001-08-15 Impact factor: 44.544
Authors: Bruce Ng; Jan Zakrzewski; Melanie Warycha; Paul J Christos; Dean F Bajorin; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Anthony Montgomery; Leonard Liebes; Peter C Brooks; Iman Osman Journal: Clin Cancer Res Date: 2008-10-01 Impact factor: 12.531
Authors: Matthew S Goldberg; John T Doucette; Henry W Lim; James Spencer; John A Carucci; Darrell S Rigel Journal: J Am Acad Dermatol Date: 2007-05-09 Impact factor: 11.527
Authors: Amaya Viros; Jane Fridlyand; Juergen Bauer; Konstantin Lasithiotakis; Claus Garbe; Daniel Pinkel; Boris C Bastian Journal: PLoS Med Date: 2008-06-03 Impact factor: 11.069
Authors: Amy E Rose; Laura Poliseno; Jinhua Wang; Michael Clark; Alexander Pearlman; Guimin Wang; Eleazar C Vega Y Saenz de Miera; Ratna Medicherla; Paul J Christos; Richard Shapiro; Anna Pavlick; Farbod Darvishian; Jiri Zavadil; David Polsky; Eva Hernando; Harry Ostrer; Iman Osman Journal: Cancer Res Date: 2011-02-22 Impact factor: 12.701
Authors: Laura Poliseno; Adele Haimovic; Miguel F Segura; Douglas Hanniford; Paul J Christos; Farbod Darvishian; Jinhua Wang; Richard L Shapiro; Anna C Pavlick; Russell S Berman; Eva Hernando; Jiri Zavadil; Iman Osman Journal: J Invest Dermatol Date: 2012-05-03 Impact factor: 8.551
Authors: Michael Lattanzi; Yesung Lee; Danny Simpson; Una Moran; Farbod Darvishian; Randie H Kim; Eva Hernando; David Polsky; Doug Hanniford; Richard Shapiro; Russell Berman; Anna C Pavlick; Melissa A Wilson; Tomas Kirchhoff; Jeffrey S Weber; Judy Zhong; Iman Osman Journal: J Natl Cancer Inst Date: 2019-02-01 Impact factor: 13.506
Authors: Amel Salhi; Joshua A Farhadian; Keith M Giles; Eleazar Vega-Saenz de Miera; Ines P Silva; Caitlin Bourque; Karen Yeh; Sagar Chhangawala; Jinhua Wang; Fei Ye; David Y Zhang; Eva Hernando-Monge; Yariv Houvras; Iman Osman Journal: Am J Pathol Date: 2015-01-08 Impact factor: 4.307
Authors: Lindsay G Wich; Heather K Hamilton; Richard L Shapiro; Anna Pavlick; Russell S Berman; David Polsky; Judith D Goldberg; Eva Hernando; Prashiela Manga; Michelle Krogsgaard; Hideko Kamino; Farbod Darvishian; Peng Lee; Seth J Orlow; Harry Ostrer; Nina Bhardwaj; Iman Osman Journal: Am J Transl Res Date: 2009-01-01 Impact factor: 4.060
Authors: Heather K Hamilton; Amy E Rose; Paul J Christos; Richard L Shapiro; Russell S Berman; Madhu Mazumdar; Michelle W Ma; Daniel Krich; Leonard Liebes; Peter C Brooks; Iman Osman Journal: J Transl Med Date: 2010-02-23 Impact factor: 5.531
Authors: José A Campillo; Isabel Legaz; M Rocío López-Álvarez; José Miguel Bolarín; Beatriz Las Heras; Manuel Muro; Alfredo Minguela; María R Moya-Quiles; Rosa Blanco-García; Helios Martínez-Banaclocha; Ana M García-Alonso; M Rocío Alvarez-López; Jorge A Martínez-Escribano Journal: Immunogenetics Date: 2013-01-31 Impact factor: 2.846
Authors: Saverio Caini; Sara Gandini; Francesca Botta; Elena Tagliabue; Sara Raimondi; Eduardo Nagore; Ines Zanna; Patrick Maisonneuve; Julia Newton-Bishop; David Polsky; DeAnn Lazovich; Rajiv Kumar; Peter A Kanetsky; Veronica Hoiom; Paola Ghiorzo; Maria Teresa Landi; Gloria Ribas; Chiara Menin; Alexander J Stratigos; Giuseppe Palmieri; Gabriella Guida; Jose Carlos García-Borrón; Hongmei Nan; Julian Little; Francesco Sera; Susana Puig; Maria Concetta Fargnoli Journal: Melanoma Res Date: 2020-10 Impact factor: 3.199